
BayPAT’s Licensee Recardio already in Phase 2 Regenerative Post-Myocardial Infarction Trial of Dutogliptin in Europe and USA
BayPAT’s Licensee Recardio already in Phase 2 Regenerative Post-Myocardial Infarction Trial of Dutogliptin in Europe and USA
BayPAT's Licensee Scintomics signed Sub-License Agreement
BayPAT out-licenses three novel radioligands to Scintomics
Startup Company Bitflux acquires technology from BayPAT
License for indoor navigation
Contact a specific team member for individual topics via the Team section or simply use our contact form. You can also click on the button and drop us a line.